Why do cells and tissues age and what are the genetic and molecular causes for aging? These are the central research questions that Italian junior scientist Dr. Francesco Neri, PhD, is trying to answer. Currently starting his own research group at Leibniz Institute on Aging (FLI) in Jena, Germany, Neri will be awarded the Sofja Kovalevskaja Award of the Alexander von Humboldt Foundation in November 2016 – one of the most highly endowed research awards in Germany.
In recent times, our understanding of aging has deeply changed. Stem cells, that are the basis for organ regeneration throughout life, start to mutate in genetic regions that regulate the epigenome, i.e. the surface and structure of our genetic information.
Francesco Neri, Junior Group Leader of the research group on “Epigenetics of Aging“ at Leibniz Institute on Aging (FLI) in Jena.
Photo: Evelyn Kästner / FLI
These mutants become clonal, increasing the risk of disease and death. Roughly half of mankind aged 70 is affected by these alterations. Italian researcher Francesco Neri investigates the fundamentals of these processes and is now awarded the Sofja Kovalevskaja Award of the Alexander von Humboldt Foundation, one of the most highly endowed research awards in Germany.
He is one out of six international young scientists from the USA, Poland/Canada, Italy, Kenia, USA/Denmark and Iran/Australia who get the opportunity to build up their own research focus and research group at a German research institute – funded by up to 1.65 million Euro each. The awards will be given to the prizewinners on November 15, 2016, in Berlin.
Big Chance for a Young Scientist
“The Sofja Kovalevskaja Award provides young researchers with a great opportunity to follow their creative research approaches on a nearly independent basis“, Prof. Dr. Karl Lenhard Rudolph, Scientific Director of Leibniz Institute on Aging (FLI), emphasizes the importance of the research award. The funding of the Alexander von Humboldt Foundation enables Francesco Neri to build up a new junior research group on “Epigenetics of Aging“ at the Institute in Jena.
The new group is focusing on the functional characterization of epigenetic alterations associated to stem cell aging. Research aims at describing these epigenetic changes and how they are selectively accumulated over the years, e.g. altered methylation patterns of the DNA. Furthermore, the research focuses on the understanding of why and how aging-associated epigenetic alterations impact stem cell function and lead to a clonal dominance and cancer development.
“I’m really happy about this prestigious award”, Dr. Neri proudly explains. “As an internationally renowned research institute in the area of aging research, the FLI offers me an optimal research environment which enables me to fully concentrate on my own research focus.”
The Laureate – Francesco Neri
Dr. Francesco Neri was born in Italy in 1981. He studied molecular biology and gained his PhD in biotechnology at the University of Siena. After a period of research at Radboud University Medical Centre in Nijmegen, Netherlands, he returned to Italy, doing postdoctoral research at the Human Genetics Foundation in Torino, where he became a research assistant in 2015. Since July 2016, Dr. Neri has been heading a junior research group at FLI.
Sofja Kovalevskaja Award for Young Promising Scientists
The Alexander von Humboldt Foundation’s Sofja Kovalevskaja Award is named after the Russian mathematician Sofja Kovalevskaja and is one of the most highly endowed research awards in Germany. Funded by the Federal Ministry of Education and Research, it is granted to young exceptionally promising researchers from abroad in recognition of outstanding academic achievements. The award is designed to enable them to embark on academic careers in Germany by establishing their own junior research groups at research institutions in Germany. The Kovalevskaja Award is endowed with up to 1.65 million Euros.
More information on the award and the awarding ceremony can be found on http://www.humboldt-foundation.de/web/start.html.
Dr. Evelyn Kästner
Leibniz Institute on Aging – Fritz Lipmann Institute (FLI), Beutenbergstr. 11, 07745 Jena, Germany
Tel.: 03641-656373, Fax: 03641-656351
The Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) is the first German research organization dedicated to biomedical aging research since 2004. More than 330 members from over 30 nations explore the molecular mechanisms underlying aging processes and age-associated diseases. For more information, please visit http://www.leibniz-fli.de.
The Leibniz Association connects 88 independent research institutions that range in focus from the natural, engineering and environmental sciences via economics, spatial and social sciences to the humanities. Leibniz Institutes address issues of social, economic and ecological relevance. They conduct knowledge-driven and applied basic research, maintain scientific infrastructure and provide research-based services. The Leibniz Association identifies focus areas for knowledge transfer to policy-makers, academia, business and the public. Leibniz Institutes collaborate intensively with universities – in the form of “WissenschaftsCampi” (thematic partnerships between university and non-university research institutes), for example – as well as with industry and other partners at home and abroad. They are subject to an independent evaluation procedure that is unparalleled in its transparency. Due to the institutes’ importance for the country as a whole, they are funded jointly by the Federation and the Länder, employing some 18,100 individuals, including 9,200 researchers. The entire budget of all the institutes is approximately 1.64 billion EUR. See http://www.leibniz-association.eu for more information.
http://www.leibniz-fli.de - Website Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) Jena
Dr. Kerstin Wagner | idw - Informationsdienst Wissenschaft
Success at leading conference on silicon materials science and technology in Japan
13.12.2018 | IHP - Leibniz-Institut für innovative Mikroelektronik
13.11.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy